We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+23.6%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
-$44.4M
Cap. Flow
-$65.4M
Cap. Flow %
-44.37%
Top 10 Hldgs %
60.34%
Holding
94
New
22
Increased
8
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$9.68M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$5.26M
3
SVRA icon
Savara
SVRA
+$5.11M
4
VERA icon
Vera Therapeutics
VERA
+$3.57M
5
INSM icon
Insmed
INSM
+$3.11M

Top Sells

Rank Stock Value
1
CBAY
Cymabay Therapeutics
CBAY
+$12.3M
2
IMGN
Immunogen Inc
IMGN
+$11.5M
3
GPCR icon
Structure Therapeutics
GPCR
+$7.82M
4
BHVN icon
Biohaven
BHVN
+$7.46M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$6.36M

Sector Composition

Rank Sector Weight
1 Healthcare 88.88%
2 Communication Services 0.3%
3 Industrials 0.07%
4 Consumer Staples 0.05%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERU icon
26
Veru
VERU
$37.1M
$1.44M 0.98%
+200,000
New +$1.77M
NGNE icon
27
Neurogene
NGNE
$710M
$1.3M 0.88%
+66,981
New +$959K
ARVN icon
28
Arvinas
ARVN
$560M
$1.28M 0.87%
+31,210
New +$730K
FBIO icon
29
Fortress Biotech
FBIO
$92M
$1.22M 0.83%
+405,122
New +$1.07M
FLNA
30
PUT
Filana Therapeutics
FLNA
$46.3M
$1.06M 0.72%
+47,000
New +$993K
DMAC icon
31
DiaMedica Therapeutics
DMAC
$365M
$817K 0.55%
287,698
-208,302
-42% -$515K
FATBW
32
DELISTED
FAT Brands Inc. Warrant
FATBW
$680K 0.46%
200,000
– –
ACXP icon
33
PUT
Acurx Pharmaceuticals
ACXP
$6.27M
$652K 0.44%
+8,515
New +$643K
KPTI icon
34
Karyopharm Therapeutics
KPTI
$44.2M
$640K 0.43%
49,333
– –
MSOS icon
35
AdvisorShares Pure US Cannabis ETF
MSOS
$874M
$561K 0.38%
+80,000
New +$532K
BTAI icon
36
PUT
BioXcel Therapeutics
BTAI
$25.6M
$499K 0.34%
+10,575
New +$588K
DDI
37
DoubleDown Interactive
DDI
$590M
$447K 0.3%
60,876
– –
RYTM icon
38
Rhythm Pharmaceuticals
RYTM
$7.72B
$298K 0.2%
+6,485
New +$205K
FLNA
39
Filana Therapeutics
FLNA
$46.3M
$293K 0.2%
+13,000
New +$275K
TNXP icon
40
Tonix Pharmaceuticals
TNXP
$186M
$218K 0.15%
+169
New +$272K
NXGLW icon
41
NexGel Inc Warrant
NXGLW
$110K 0.07%
225,000
– –
BGMS
42
Bio Green Med Solution Inc
BGMS
$5.35M
$101K 0.07%
+158
New +$227K
WLDSW icon
43
Wearable Devices Ltd Warrant
WLDSW
$132K
$98.8K 0.07%
1,961
– –
MBTCR
44
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$82.4K 0.06%
500,000
– –
SDOT icon
45
Sadot Group
SDOT
$13.3M
$67.4K 0.05%
84
-349
-81% -$408K
ONFOW icon
46
Onfolio Holdings Warrant
ONFOW
$75.1K
$16K 0.01%
200,000
– –
SDEV
47
Stablecoin Development Corp
SDEV
$52.5M
$13.8K 0.01%
+385
New +$21.9K
NLSPW
48
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$11.2K 0.01%
200,000
– –
PEPLW
49
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$11.1K 0.01%
367,500
– –
MOBXW icon
50
Mobix Labs Warrants
MOBXW
$752K
$10.5K 0.01%
150,000
– –
1
2
3 4

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return

Altium Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Altium Capital Management held 94 positions worth $147M, down 23% from $192M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Altium Capital Management withdrew a net $65.4M in Q4 2023, closing 28 positions and reducing 10 holdings. Its most notable exit was Immunogen Inc, an estimated $11.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Altium Capital Management opened a new position in Alpha Architect 1-3 Month Box ETF worth $9.75M.

  • Altium Capital Management's largest Q4 2023 buy was Alpha Architect 1-3 Month Box ETF: 92,700 shares worth $9.75M.
  • Altium Capital Management added most to Vera Therapeutics in Q4 2023, an estimated $3.57M increase.
  • Altium Capital Management's biggest Q4 2023 reduction was Cymabay Therapeutics, cutting an estimated $12.3M.
  • Altium Capital Management fully exited Immunogen Inc in Q4 2023, selling an estimated $11.5M.
  • Altium Capital Management's ten largest holdings make up 60% of its $147M portfolio in Q4 2023.
  • Altium Capital Management opened 22 new positions and closed 28 in Q4 2023.
  • Altium Capital Management's portfolio value fell 23% quarter-over-quarter to $147M.

Based on Altium Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.